查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
牙科人工骨替代材料的全球市場：類型（異質骨移植、同種異體移植、合成骨移植、同種異體）、應用（鼻竇增高術、齒槽嵴增強、齒槽保留）、產品（BioOss、Osteograf、 Grafton）,依最終使用者/地區- 預測（至 2029 年）
市場調查報告書
商品編碼
1480022

牙科人工骨替代材料的全球市場：類型（異質骨移植、同種異體移植、合成骨移植、同種異體）、應用（鼻竇增高術、齒槽嵴增強、齒槽保留）、產品（BioOss、Osteograf、 Grafton）,依最終使用者/地區- 預測（至 2029 年）

Dental Bone Graft Substitutes Market by Type (Xenograft, Allograft, Synthetic Bone Grafts, Alloplast), Application (Sinus Lift, Ridge Augumentation, Socket Preservation), Product (BioOss, Osteograf, Grafton), End User, Region- Global Forecast to 2029
出版日期: | 出版商: MarketsandMarkets | 英文 284 Pages | 訂單完成後即時交付

價格
簡介目錄

全球牙科人工骨替代材料市場規模預計將從 2024 年的 13 億美元成長到 2029 年的 18 億美元，預測期內複合年成長率為 7.7%。

調查範圍
調查年份 2022-2029
基準年 2023年
預測期 2024-2029
單元 金額（美元）
部分 類型、應用、機制、產品、最終用戶、地區
目標區域 亞太地區、北美、拉丁美洲、中東和非洲以及海灣合作理事會國家

老年人口的成長增加了牙齒脫落和下顎骨劣化的影響，這可能需要骨頭移植術。人工植牙提供了一種外觀自然且功能齊全的牙齒替換選擇，推動了對骨移植以支持植入植入的需求，從而促進了市場成長。然而，嚴格的監管合規性和供應鏈管理的複雜性預計將在一定程度上限制市場的成長。

從機制上看，骨傳導領域預計將呈現市場上最高的複合年成長率：

骨傳導材料的進步使得能夠開發出更小、更容易處理的骨移植顆粒。這有利於微創骨頭移植術並加速患者復原。骨傳導材料也為骨細胞生長提供支架或框架，刺激人體自然骨癒合過程並促進新骨組織的形成。

從應用來看，鼻竇增高術類別預計將顯示出最高的複合年成長率：

牙科人工骨替代材料在鼻竇增高術手術中發揮重要作用。例如，自體骨移植使用患者自己的骨頭，通常取自脛骨、髖部、下顎或下顎。儘管自體骨移植在骨形成方面具有巨大潛力，但其使用可能會受到供體部位不足和骨供應的限制。

按類型分類，合成骨移植段預計具有最高的複合年成長率：

合成骨移植物通常由生物相容性材料組成，例如羥磷石灰（類似天然骨的礦物質成分）、磷酸鈣和生物聚合物。這些材料為骨生長提供支架，並促進植入部位新骨的形成。

從產品來看，BioOss 預計將顯示出最高的複合年成長率：

Bio-Oss 為骨細胞遷移、附著和增殖提供了框架，從而促進骨再生。 Bio-Oss 的主要成分是牛質骨顆粒，採用取得專利的方法加工，去除有機物，同時保留礦物質結構。這創造了一種高度生物相容性的支架，忠實地模仿人類骨骼，為新骨的合成創造了最佳環境。

本報告調查了全球牙科人工骨替代材料市場，並提供市場概況、市場影響因素和市場機會分析、技術和專利趨勢、法律制度、案例研究、市場規模趨勢和預測，我們按各個類別編制詳細分析/地區/主要國家、競爭格局、主要企業概況等

目錄

第1章簡介

第2章調查方法

第3章執行摘要

第 4 章重要考察

第5章市場概況

  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
    • 任務

第6章 產業趨勢

  • 加強產學合作
  • 美國和英國牙科投資活躍
  • 技術分析
    • 無氣噴嘴技術
  • 生物陶瓷
  • 價格分析
  • 關稅和監管狀況
  • 監管機構、政府機構和其他組織
  • 價值鏈分析
  • 波特五力分析
  • 供應鏈分析
  • 貿易分析
  • 專利分析
  • 牙科人工骨替代材料的專利公佈趨勢
  • 司法管轄區分析：牙科人工骨替代材料市場的頂級專利申請人
  • 案例研究
  • 主要會議及活動
  • 主要相關利益者和採購標準
  • 生態系/市場地圖
  • 鄰近市場分析
  • 影響客戶業務的趨勢/干擾
  • 牙科人工骨替代材料市場：需求未被滿足
  • 人工智慧在牙科人工骨替代材料市場中的作用
  • 投資/創業投資

第7章牙科人工骨替代材料市場：依應用分類

  • 套接字保存
  • 齒槽嵴增高
  • 牙周缺損再生
  • 植入骨再生
  • 鼻竇增高術

第8章牙科人工骨替代材料市場：依最終用戶分類

  • 醫院
  • 牙醫診所
  • 其他

第9章牙科人工骨替代材料市場：按機制

  • 骨傳導
  • 骨誘導
  • 骨質促進
  • 骨形成

第 10 章牙科人工骨替代材料市場：依產品

  • BioOss
  • Osteograf
  • Grafton
  • 其他產品

第11章牙科人工骨替代材料市場：按類型

  • 合成骨移植物
  • 異質骨移植
  • 同種異體移植物
  • 自體移植物
  • 異質體
  • 脫鈣同種異體移植物
  • 其他類型

第12章牙科人工骨替代材料市場：按地區

  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲
  • 海灣合作理事會國家

第13章競爭格局

  • 主要市場趨勢
  • 主要企業策略
  • 主要市場公司收益分析
  • 市場佔有率分析
  • 競爭現狀及趨勢
  • 企業評價矩陣：主要企業
  • 公司評估矩陣：新興企業/中小企業
  • 品牌/產品比較分析
  • 主要企業研發費用
  • 投資狀況
  • 牙科人工骨替代材料市場評估和財務矩陣

第14章 公司簡介

  • 主要企業
    • DENTSPLY SIRONA INC.
    • ENVISTA HOLDINGS CORPORATION
    • JOHNSON & JOHNSON
    • INSTITUT STRAUMANN AG
    • MEDTRONIC, PLC
    • ZIMVIE INC.
    • HENRY SCHEIN, INC.
    • RTI SURGICAL
    • LIFENET HEALTH
    • DENTIUM CO., LTD.
    • GEISTLICH PHARMA AG
    • STRYKER CORPORATION
    • INTEGRA LIFESCIENCES HOLDINGS CORPORATION
    • TISSUE REGENIX GROUP PLC
    • KURARAY CO., LTD.
    • BEGO GMBH & CO. KG
    • YOUNG INNOVATIONS
    • KEYSTONE DENTAL
  • 其他公司
    • NOVABONE
    • BOTISS BIOMATERIALS GMBH
    • REGENITY
    • OSTEOGENICS BIOMEDICAL
    • HANNOX INTERNATIONAL CORP.
    • MEYER-HAAKE GMBH
    • AROA BIOSURGERY LTD.

第15章附錄

簡介目錄
Product Code: MD 4392

The global dental bone graft substitute market is projected to reach USD 1.8 billion in 2029 from USD 1.3 billion in 2024, at a CAGR of 7.7% between 2024 and 2029.

Scope of the Report
Years Considered for the Study2022-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD) Billion
SegmentsDental bone graft substitute - Type, Application, Mechanism, Product, End User and Region
Regions coveredAsia Pacific, North America, Europe, Latin America, and the Middle East and Africa and GCC countries

The growing elderly population is more susceptible to tooth loss and jawbone deterioration, potentially requiring bone grafting procedures. Dental implants offer a natural-looking and functional tooth replacement option, driving the demand for bone grafts to support implant placement which further contributes to market growth. On the other hand, stringent regulatory compliance and complexities in supply chain management are expected to limit market growth to a certain extent.

"Based on the mechanism, the osteoconduction segment is expected to grow by the highest CAGR in the dental bone graft substitute market."

Advancements in osteoconductive materials allow for the development of smaller and more manageable bone graft particles. This facilitates minimally invasive surgical techniques for bone grafting procedures, leading to faster patient recovery also osteoconductive materials provide a scaffold or framework for bone cells to grow on and migrate into. This stimulates the body's natural bone healing process, promoting the formation of new bone tissue which is expected to drive the market growth.

"The sinus lift segment in application segment is expected to grow with the highest CAGR in the dental bone graft substitute market."

Dental bone graft substitutes play a crucial role in sinus lift procedures, a surgical technique used to increase jawbone height in the upper jaw before dental implant placement which is expected to drive the market growth. For instance, In autografts, the patient's own bone is used, usually from the tibia, hip, chin, or jaw. Even while autografts have a great potential for osteogenesis, their use can result in donor site morbidity and limited bone supply.

"Based on the type, synthetic bone graft segment is expected to grow by the highest CAGR in the dental bone graft substitute market.

Synthetic bone grafts are typically composed of biocompatible materials like hydroxyapatite (similar to the mineral component of natural bone), calcium phosphates, or biopolymers. These materials provide a scaffold for bone ingrowth, promoting new bone formation at the graft site which is expected to drive the dental bone graft substitute market.

"Based on the product, bio OSS segment is expected to grow by the highest CAGR in the dental bone graft substitute market.

Bio-Oss provides a framework for bone cells to migrate, attach, and proliferate, promoting bone regeneration, Bio-Oss is used to augment the jawbone ridge before dental implant placement, providing a strong foundation for the implant which is expected to drive the dental bone graft substitute market. The main ingredient of Bio-Oss is processed bovine cancellous bone particles through a patented method that eliminates organic materials while maintaining the mineral structure. As a result, a biocompatible scaffold that closely mimics human bone is created, creating the perfect setting for the synthesis of new bone.

"Based on the end user, hospital segment is expected to grow by the highest CAGR in the dental bone graft substitute market.

Dental bone graft substitutes are increasingly valuable tools in hospital dentistry, offering a range of benefits for patients undergoing dental implant procedures, oral surgery, and treatments for jawbone defects. As technology advances and costs become more manageable, these materials are likely to play an even more prominent role in improving patient outcomes and expanding treatment options which is expected to drive the dental bone graft substitute market.

"North America to grow with the second highest CAGR in the dental bone graft substitute market during the forecast period."

The growing elderly population in North America is more susceptible to tooth loss and jawbone deterioration, potentially requiring bone grafting procedures to support dental implants or other restorative treatments are fueling the expansion of the dental bone graft substitute market in North America.

Europe was the second largest segment in the dental bone graft substitute market in 2023. The Germany accounted for the larger share of the European dental bone graft substitute market in 2023. The rising number of dental disorders and and growing awareness regarding dental bone graft substitute is expected to drive the market growth in Europen market.

A breakdown of the primary participants (supply-side) for the dental bone graft substitute market referred to for this report is provided below:

  • By Company Type: Tier 40%, Tier 35%, and Tier 25%
  • By Designation: C-level-30%, Director Level-55%, and Others-15%
  • By Region: North America-20%, Europe-15%, Asia Pacific-25%, Latin America- 10%, Middle East & Africa-30%.

Prominent players in the dental bone graft substitute market include Dentsply Sirona Inc. (US), Envista Holdings Corporation (US), JOHNSON & JOHNSON (US), Stryker Corporation (US), Medtronic, Plc (Ireland), Institut Straumann AG (Switzerland), Zimvie Inc. (US), Henry Schein Inc. (US), RTI Surgical Holdings Inc.(US), Lifenet Health (US), Dentium (US), Geistlich Pharma AG (Switzerland), Integra Lifesciences Holdings Corporation (US), Tissue Regenix Group (UK), Kuraray Co. Ltd. (Japan), BEGO GmbH & Co. KG (Germany), Young Innovations (US), Keystone Dental (US), Novabone LLC. (US), Biotiss Biomaterials LLC (US), Collagen Matrix Inc.(US), Osteogenics Biomedical (US), Hannox International Corp.(Taiwan), Meyer Haake GMBH (Germany) and Arora Biosurgery Ltd. (New Zealand).

Research Coverage:

The report analyzes the dental bone graft substitute market and aims at estimating the market size and future growth potential of this market based on various segments such as type, application, mechanism, product, end user and region. The report also includes a competitive analysis of the key players in this market along with their company profiles, product/service offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall dental bone graft substitute market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

  • Analysis of key drivers (growing market for dental tourism in emerging countries, increasing disposable income in developing counties, rising cases of dental caries and the subsequent increase in tooth repair procedures, changing demographics), restraints (lack of proper reimbursement scenario, stringent regulations pertaining to medical devices used in dentistry, dearth of trained dental practitioners), opportunities (increasing demand from customers and rising inclination towards cosmetic dentistry, low penetration rates for dental bone graft substitutes, consolidation of dental practices and rising dso activity, growing demand for bone graft substitutes from emerging markets) and challenges (pricing pressure faced by prominent market players)
  • Market Penetration: It includes extensive information on product portfolios offered by the major players in the global dental bone graft substitute market. The report includes various segments in market type, application, mechanism, product, end user and region
  • Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global dental bone graft substitute market.
  • Market Development: Thorough knowledge and analysis of the profitable rising markets type, application, mechanism, product, end user and region
  • Market Diversification: Comprehensive information about newly launched product and services, expanding markets, current advancements, and investments in the global dental bone graft substitute market.
  • Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of product and services, and capacities of the major competitors in the global dental bone graft substitute market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKET SEGMENTATION
    • 1.3.2 REGIONS COVERED
  • 1.4 YEARS CONSIDERED
  • 1.5 CURRENCY CONSIDERED
    • TABLE 1 STANDARD CURRENCY CONVERSION RATES, 2018-2022
  • 1.6 KEY STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES
    • 1.7.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 KEY PRIMARY SOURCES
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
    • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 6 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
    • FIGURE 7 REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF TISSUE REGENIX GROUP PLC
    • FIGURE 8 DENTAL BONE GRAFT SUBSTITUTES MARKET: SUPPLY-SIDE MARKET SIZE ESTIMATION
    • FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    • FIGURE 11 TOP-DOWN APPROACH
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 12 DATA TRIANGULATION METHODOLOGY
  • 2.4 RESEARCH ASSUMPTIONS
  • 2.5 LIMITATIONS
    • 2.5.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.6 RISK ASSESSMENT
  • 2.7 IMPACT OF RECESSION

3 EXECUTIVE SUMMARY

    • FIGURE 13 SYNTHETIC BONE GRAFT SEGMENT TO LEAD MARKET BY 2029
    • FIGURE 14 SOCKET PRESERVATION SEGMENT TO ACCOUNT FOR LARGEST SHARE IN 2024
    • FIGURE 15 OSTEOCONDUCTION SEGMENT TO LEAD MARKET BY 2029
    • FIGURE 16 BIO-OSS SEGMENT TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
    • FIGURE 17 HOSPITALS SEGMENT TO ACCOUNT FOR LARGEST SHARE BY 2029
    • FIGURE 18 DENTAL BONE GRAFT SUBSTITUTES MARKET: REGIONAL SNAPSHOT

4 PREMIUM INSIGHTS

  • 4.1 OPPORTUNITIES FOR PLAYERS IN DENTAL BONE GRAFT SUBSTITUTES MARKET
    • FIGURE 19 RISING TECHNOLOGICAL ADVANCEMENTS TO DRIVE GROWTH OF DENTAL BONE GRAFT SUBSTITUTES MARKET
  • 4.2 NORTH AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER
    • FIGURE 20 HOSPITALS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • 4.3 DENTAL BONE GRAFT SUBSTITUTES MARKET: GEOGRAPHIC SNAPSHOT
    • FIGURE 21 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • 4.4 DENTAL BONE GRAFT SUBSTITUTES MARKET: REGIONAL MIX
    • FIGURE 22 NORTH AMERICA TO BE LARGEST MARKET FOR DENTAL BONE GRAFT SUBSTITUTES DURING FORECAST PERIOD
  • 4.5 DENTAL BONE GRAFT SUBSTITUTES MARKET: DEVELOPED VS. DEVELOPING MARKETS
    • FIGURE 23 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 24 DENTAL BONE GRAFT SUBSTITUTES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing market for dental tourism in emerging countries
      • 5.2.1.2 Increasing disposable income in developing countries
      • 5.2.1.3 Rising cases of dental caries and subsequent increase in tooth repair procedures
      • 5.2.1.4 Changing demographics
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Lack of proper reimbursement scenario
      • 5.2.2.2 Stringent regulations pertaining to medical devices used in dentistry
      • 5.2.2.3 Dearth of trained dental practitioners
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Increasing demand from customers and rising inclination toward cosmetic dentistry
      • 5.2.3.2 Low penetration rates for dental bone graft substitutes
      • 5.2.3.3 Consolidation of dental practices and rising DSO activity
      • 5.2.3.4 Growing demand for bone graft substitutes from emerging markets
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Pricing pressure faced by prominent market players

6 INDUSTRY TRENDS

  • 6.1 RISING NUMBER OF INDUSTRY-ACADEMIA COLLABORATIONS
  • 6.2 HIGH INVESTMENT ACTIVITY IN DENTAL PRACTICES IN US AND UK
    • TABLE 2 EXAMPLES OF RECENT DEALS BACKED BY PRIVATE EQUITY IN US, 2020-2023
  • 6.3 TECHNOLOGY ANALYSIS
    • 6.3.1 GASLESS SPRAY TIP TECHNOLOGY
  • 6.4 BIO CERAMICS
  • 6.5 PRICING ANALYSIS
    • TABLE 3 AVERAGE SELLING PRICE TREND FOR KEY TYPES OF DENTAL BONE GRAFT SUBSTITUTES, BY REGION, 2021 (USD)
    • TABLE 4 AVERAGE SELLING PRICE TREND FOR KEY TYPES OF DENTAL BONE GRAFT SUBSTITUTES, BY REGION, 2022 (USD)
  • 6.6 TARIFF AND REGULATORY LANDSCAPE
    • 6.6.1 REGULATORY ANALYSIS
      • 6.6.1.1 US
      • 6.6.1.2 European Union
      • 6.6.1.3 China
  • 6.7 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 5 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 6 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 7 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 6.8 VALUE CHAIN ANALYSIS
    • FIGURE 25 VALUE CHAIN ANALYSIS
  • 6.9 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 8 PORTER'S FIVE FORCES ANALYSIS
    • 6.9.1 THREAT OF NEW ENTRANTS
    • 6.9.2 THREAT OF SUBSTITUTES
    • 6.9.3 BARGAINING POWER OF SUPPLIERS
    • 6.9.4 BARGAINING POWER OF BUYERS
    • 6.9.5 INTENSITY OF COMPETITIVE RIVALRY
  • 6.10 SUPPLY CHAIN ANALYSIS
    • FIGURE 26 SUPPLY CHAIN ANALYSIS
  • 6.11 TRADE ANALYSIS
    • TABLE 9 VALUE OF INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, DENTAL, OR VETERINARY SCIENCES EXPORTED FROM US, 2019-2022 (000')
  • 6.12 PATENT ANALYSIS
  • 6.13 PATENT PUBLICATION TRENDS FOR DENTAL BONE GRAFT SUBSTITUTES
    • FIGURE 27 PATENT PUBLICATION TRENDS (JANUARY 2013-SEPTEMBER 2023)
  • 6.14 JURISDICTION ANALYSIS: TOP APPLICANTS FOR PATENTS IN DENTAL BONE GRAFT SUBSTITUTES MARKET
    • FIGURE 28 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR DENTAL BONE GRAFT SUBSTITUTES (JANUARY 2013-MARCH 2024)
    • FIGURE 29 TOP PATENT APPLICANT COUNTRIES FOR DENTAL BONE GRAFT SUBSTITUTES (JANUARY 2013-MARCH 2024)
  • 6.15 CASE STUDIES
    • 6.15.1 IDENTIFYING PREFERRED ANTIMICROBIAL AGENTS AND COATING SUBSTANCES USED FOR IMPLANT COATINGS
    • 6.15.2 ANALYZING SHARE OF RADIOGRAPHY SYSTEMS IN DENTISTRY MARKET
  • 6.16 KEY CONFERENCES & EVENTS
    • TABLE 10 DETAILED LIST OF CONFERENCES & EVENTS
  • 6.17 KEY STAKEHOLDERS & BUYING CRITERIA
    • 6.17.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
    • TABLE 11 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
    • 6.17.2 BUYING CRITERIA
    • FIGURE 31 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
  • 6.18 ECOSYSTEM/MARKET MAP
    • FIGURE 32 ECOSYSTEM/MARKET MAP
    • 6.18.1 ROLE OF PLAYERS IN MARKET ECOSYSTEM
  • 6.19 ADJACENT MARKET ANALYSIS
    • FIGURE 33 DENTAL BONE GRAFT SUBSTITUTES MARKET: ADJACENT MARKETS
  • 6.20 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • FIGURE 34 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 6.21 DENTAL BONE GRAFT SUBSTITUTES MARKET: UNMET NEEDS
  • 6.22 ROLE OF ARTIFICIAL INTELLIGENCE (AI) IN DENTAL BONE GRAFT SUBSTITUTES MARKET
  • 6.23 INVESTMENT/VENTURE CAPITAL

7 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
    • TABLE 12 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • 7.2 SOCKET PRESERVATION
    • 7.2.1 SOCKET PRESERVATION REDUCES BONE LOSS AFTER TOOTH EXTRACTION
    • TABLE 13 SOCKET PRESERVATION: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
  • 7.3 RIDGE AUGMENTATION
    • 7.3.1 RIDGE AUGMENTATION RECREATES NATURAL CONTOUR OF GUMS AND JAW
    • TABLE 14 RIDGE AUGMENTATION: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
  • 7.4 PERIODONTAL DEFECT REGENERATION
    • 7.4.1 CHANGES IN LIFESTYLE AND EATING HABITS TO LEAD TO USE OF DENTAL BONE GRAFT SUBSTITUTES FOR PERIODONTAL DEFECT REGENERATION
    • TABLE 15 PERIODONTAL DEFECT REGENERATION: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
  • 7.5 IMPLANT BONE REGENERATION
    • 7.5.1 UTILIZATION OF GUIDED BONE REGENERATION MEMBRANES FACILITATES HEALING OF GRAFTED MATERIAL
    • TABLE 16 IMPLANT BONE REGENERATION: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
  • 7.6 SINUS LIFT
    • 7.6.1 SINUS AUGMENTATION RAISES SINUS FLOOR AND DEVELOPS BONE FOR PLACEMENT OF DENTAL IMPLANTS
    • TABLE 17 SINUS LIFT: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)

8 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER

  • 8.1 INTRODUCTION
    • TABLE 18 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 8.2 HOSPITALS
    • 8.2.1 INCREASING NUMBER OF COSMETIC DENTISTRY PROCEDURES ACROSS HOSPITALS TO DRIVE MARKET GROWTH
    • TABLE 19 HOSPITALS: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
  • 8.3 DENTAL CLINICS
    • 8.3.1 HIGH-QUALITY SERVICES RENDERED BY DENTAL CLINICS' STAFF TO DRIVE MARKET GROWTH
    • TABLE 20 NUMBER OF DENTAL CLINICS, BY COUNTRY, 2020 VS. 2022
    • TABLE 21 DENTAL CLINICS: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
  • 8.4 OTHER END USERS
    • TABLE 22 OTHER END USERS: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)

9 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM

  • 9.1 INTRODUCTION
    • TABLE 23 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
  • 9.2 OSTEOCONDUCTION
    • 9.2.1 OSTEOCONDUCTION SERVES AS SCAFFOLD FOR BONE CELLS TO ATTACH, MIGRATE, GROW, AND DIVIDE
    • TABLE 24 OSTEOCONDUCTION: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
  • 9.3 OSTEOINDUCTION
    • 9.3.1 OSTEOINDUCTION FACILITATES BONE HEALING PROCESS
    • TABLE 25 OSTEOINDUCTION: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
  • 9.4 OSTEOPROMOTION
    • 9.4.1 OSTEOPROMOTION INVOLVES ENHANCEMENT OF OSTEOINDUCTION WITHOUT POSSESSION OF OSTEOINDUCTIVE PROPERTIES
    • TABLE 26 OSTEOPROMOTION: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
  • 9.5 OSTEOGENESIS
    • 9.5.1 OSTEOGENESIS PLAYS CRUCIAL ROLE IN FACILITATING SUCCESSFUL BONE REGENERATION AND REPAIR
    • TABLE 27 OSTEOGENESIS: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)

10 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT

  • 10.1 INTRODUCTION
    • TABLE 28 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • 10.2 BIO-OSS
    • 10.2.1 HIGH IMPLANT SURVIVAL RATES ASSOCIATED WITH BIO-OSS PRODUCTS TO DRIVE MARKET GROWTH
    • TABLE 29 BIO-OSS: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
  • 10.3 OSTEOGRAF
    • 10.3.1 NON-POROUS AND RESORBABLE NATURE OF OSTEOGRAF TO DRIVE MARKET GROWTH
    • TABLE 30 OSTEOGRAF: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
  • 10.4 GRAFTON
    • 10.4.1 INCREASED SAFETY AND LIMITED POSSIBILITY OF DISEASE TRANSMISSION TO BOOST DEMAND FOR GRAFTON
    • TABLE 31 GRAFTON: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
  • 10.5 OTHER PRODUCTS
    • TABLE 32 OTHER PRODUCTS: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)

11 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE

  • 11.1 INTRODUCTION
    • TABLE 33 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • 11.2 SYNTHETIC BONE GRAFT
    • 11.2.1 INCREASING TECHNOLOGICAL ADVANCEMENTS TO INCREASE ADOPTION OF SYNTHETIC BONE GRAFT
    • TABLE 34 SYNTHETIC BONE GRAFT: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
  • 11.3 XENOGRAFT
    • 11.3.1 TECHNOLOGICAL ADVANCEMENTS IN USE OF XENOGRAFT MATERIALS AND SCARCITY OF ALLOGRAFT MATERIALS TO DRIVE MARKET
    • TABLE 35 XENOGRAFT: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
  • 11.4 ALLOGRAFT
    • 11.4.1 INCREASED OPERATING TIMELINES AND POTENTIAL COMPLICATIONS AND MORBIDITY OF HARVEST SITE TO BOOST USE OF ALLOGRAFT
    • TABLE 36 ALLOGRAFT: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
  • 11.5 AUTOGRAFT
    • 11.5.1 LITTLE SCOPE FOR DISEASE TRANSMISSION FROM GRAFT MATERIALS TO DRIVE ADOPTION OF AUTOGRAFT
    • TABLE 37 AUTOGRAFT: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
  • 11.6 ALLOPLAST
    • 11.6.1 ALLOPLAST MATERIALS PROMOTE BONE HEALING THROUGH OSTEOCONDUCTION
    • TABLE 38 ALLOPLAST: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
  • 11.7 DEMINERALIZED ALLOGRAFT
    • 11.7.1 DEMINERALIZED ALLOGRAFT POSSESSES MORE OSTEOINDUCTIVE PROPERTIES THAN REGULAR ALLOGRAFT
    • TABLE 39 DEMINERALIZED ALLOGRAFT: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
  • 11.8 OTHER TYPES
    • TABLE 40 OTHER TYPES: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)

12 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY REGION

  • 12.1 INTRODUCTION
    • FIGURE 35 US TO DOMINATE DENTAL BONE GRAFT SUBSTITUTES MARKET DURING FORECAST PERIOD
    • TABLE 41 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
  • 12.2 NORTH AMERICA
    • TABLE 42 US: DENTAL EXPENDITURE, 2011-2020
    • 12.2.1 NORTH AMERICA: RECESSION IMPACT ANALYSIS
    • FIGURE 36 NORTH AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET SNAPSHOT
    • TABLE 43 NORTH AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
    • TABLE 44 NORTH AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 45 NORTH AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 46 NORTH AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 47 NORTH AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
    • TABLE 48 NORTH AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 12.2.2 US
      • 12.2.2.1 Increasing patient awareness about advantages of dental bone graft substitutes over traditional treatments to boost growth
    • TABLE 49 US: MACROECONOMIC INDICATORS
    • TABLE 50 US: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 51 US: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 52 US: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 53 US: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
    • TABLE 54 US: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 12.2.3 CANADA
      • 12.2.3.1 Rising geriatric population to propel market expansion
    • TABLE 55 CANADA: MACROECONOMIC INDICATORS
    • TABLE 56 CANADA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 57 CANADA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 58 CANADA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 59 CANADA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
    • TABLE 60 CANADA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 12.3 EUROPE
    • 12.3.1 EUROPE: RECESSION IMPACT ANALYSIS
    • FIGURE 37 EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET SNAPSHOT
    • TABLE 61 EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
    • TABLE 62 EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 63 EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 64 EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 65 EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
    • TABLE 66 EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 12.3.2 GERMANY
      • 12.3.2.1 Country's robust health insurance system to drive popularity of dental bone graft substitutes
    • TABLE 67 GERMANY: MACROECONOMIC INDICATORS
    • TABLE 68 GERMANY: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 69 GERMANY: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 70 GERMANY: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 71 GERMANY: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
    • TABLE 72 GERMANY: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 12.3.3 UK
      • 12.3.3.1 Preference for costly procedures due to availability of reimbursement facilities to lead to potential growth
    • TABLE 73 UK: MACROECONOMIC INDICATORS
    • TABLE 74 UK: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 75 UK: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 76 UK: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 77 UK: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
    • TABLE 78 UK: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 12.3.4 FRANCE
      • 12.3.4.1 Rising awareness among people regarding benefits of dental bone graft substitutes and presence of major players to drive growth
    • TABLE 79 FRANCE: MACROECONOMIC INDICATORS
    • TABLE 80 FRANCE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 81 FRANCE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 82 FRANCE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 83 FRANCE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
    • TABLE 84 FRANCE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 12.3.5 ITALY
      • 12.3.5.1 Intensive R&D and use of sophisticated materials to manufacture advanced products to propel market
    • TABLE 85 ITALY: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 86 ITALY: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 87 ITALY: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 88 ITALY: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
    • TABLE 89 ITALY: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 12.3.6 SPAIN
      • 12.3.6.1 Government initiatives to provide dental cover to people to boost market
    • TABLE 90 SPAIN: MACROECONOMIC INDICATORS
    • TABLE 91 SPAIN: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 92 SPAIN: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 93 SPAIN: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 94 SPAIN: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
    • TABLE 95 SPAIN: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 12.3.7 REST OF EUROPE
    • TABLE 96 REST OF EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 97 REST OF EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 98 REST OF EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 99 REST OF EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
    • TABLE 100 REST OF EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 12.4 ASIA PACIFIC
    • TABLE 101 DENTAL IMPLANTS PER 10,000 PEOPLE AND AVERAGE NUMBER OF IMPLANTS PLACED PER DENTIST, 2020
    • 12.4.1 ASIA PACIFIC: RECESSION IMPACT ANALYSIS
    • FIGURE 38 ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET SNAPSHOT
    • TABLE 102 ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
    • TABLE 103 ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 104 ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 105 ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 106 ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
    • TABLE 107 ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 12.4.2 JAPAN
      • 12.4.2.1 Increasing awareness, availability of reimbursement, and growing income levels to offer growth opportunities for market players
    • TABLE 108 JAPAN: MACROECONOMIC INDICATORS
    • TABLE 109 JAPAN: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 110 JAPAN: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 111 JAPAN: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 112 JAPAN: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
    • TABLE 113 JAPAN: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION
    • 12.4.3 CHINA
      • 12.4.3.1 Growing geriatric population, economic boom, and increasing per capita income to propel growth
    • TABLE 114 CHINA: MACROECONOMIC INDICATORS
    • TABLE 115 CHINA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 116 CHINA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 117 CHINA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 118 CHINA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
    • TABLE 119 CHINA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION
    • 12.4.4 INDIA
      • 12.4.4.1 Diverse, lucrative opportunities offered to dental product and service providers to ensure adequate market progress
    • TABLE 120 INDIA: MACROECONOMIC INDICATORS
    • TABLE 121 INDIA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 122 INDIA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 123 INDIA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 124 INDIA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
    • TABLE 125 INDIA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION
    • 12.4.5 AUSTRALIA
      • 12.4.5.1 Popularity of xenograft and allograft to open new opportunities for growth of market players
    • TABLE 126 AUSTRALIA: ORAL HEALTH STATUS OF CHILDREN AND ADULTS
    • TABLE 127 AUSTRALIA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 128 AUSTRALIA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 129 AUSTRALIA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 130 AUSTRALIA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
    • TABLE 131 AUSTRALIA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 12.4.6 SOUTH KOREA
      • 12.4.6.1 Rising geriatric population and medical tourism to drive market
    • TABLE 132 NUMBER OF FOREIGN PATIENTS VISITING DENTAL FACILITIES IN SOUTH KOREA
    • TABLE 133 SOUTH KOREA: MACROECONOMIC INDICATORS
    • TABLE 134 SOUTH KOREA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 135 SOUTH KOREA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 136 SOUTH KOREA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 137 SOUTH KOREA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
    • TABLE 138 SOUTH KOREA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION
    • 12.4.7 REST OF ASIA PACIFIC
    • TABLE 139 REST OF ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 140 REST OF ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 141 REST OF ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 142 REST OF ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
    • TABLE 143 REST OF ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION
  • 12.5 LATIN AMERICA
    • 12.5.1 LATIN AMERICA: RECESSION IMPACT ANALYSIS
    • TABLE 144 LATIN AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022-2029 (USD MILLION)
    • TABLE 145 LATIN AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 146 LATIN AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 147 LATIN AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 148 LATIN AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
    • TABLE 149 LATIN AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 12.5.2 BRAZIL
      • 12.5.2.1 Improving healthcare infrastructure and rising investments by leading players to spur demand
    • TABLE 150 BRAZIL: MACROECONOMIC INDICATORS
    • TABLE 151 BRAZIL: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 152 BRAZIL: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 153 BRAZIL: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 154 BRAZIL: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
    • TABLE 155 BRAZIL: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 12.5.3 MEXICO
      • 12.5.3.1 Rising medical tourism to support market growth
    • TABLE 156 MEXICO: MACROECONOMIC INDICATORS
    • TABLE 157 MEXICO: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 158 MEXICO: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 159 MEXICO: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 160 MEXICO: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
    • TABLE 161 MEXICO: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 12.5.4 ARGENTINA
      • 12.5.4.1 Growing demand for personalized dentistry to spur market demand
    • TABLE 162 ARGENTINA: MACROECONOMIC INDICATORS
    • TABLE 163 ARGENTINA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 164 ARGENTINA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 165 ARGENTINA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 166 ARGENTINA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
    • TABLE 167 ARGENTINA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 12.5.5 REST OF LATIN AMERICA
    • TABLE 168 REST OF LATIN AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 169 REST OF LATIN AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 170 REST OF LATIN AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 171 REST OF LATIN AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
    • TABLE 172 REST OF LATIN AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 12.6 MIDDLE EAST & AFRICA
    • 12.6.1 GROWING INVESTMENTS IN DIGITAL HEALTHCARE INDUSTRY TO BOOST DEMAND FOR DENTAL BONE GRAFT SUBSTITUTES
    • 12.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT ANALYSIS
    • TABLE 173 MIDDLE EAST & AFRICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 174 MIDDLE EAST & AFRICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 175 MIDDLE EAST & AFRICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 176 MIDDLE EAST & AFRICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
    • TABLE 177 MIDDLE EAST & AFRICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 12.7 GCC COUNTRIES
    • 12.7.1 INCREASING DEMAND FOR HEALTH SERVICES DUE TO POPULATION GROWTH TO DRIVE MARKET FOR DENTAL BONE GRAFT SUBSTITUTES
    • 12.7.2 GCC COUNTRIES: RECESSION IMPACT ANALYSIS
    • TABLE 178 GCC COUNTRIES: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 179 GCC COUNTRIES: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 180 GCC COUNTRIES: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
    • TABLE 181 GCC COUNTRIES: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022-2029 (USD MILLION)
    • TABLE 182 GCC COUNTRIES: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022-2029 (USD MILLION)

13 COMPETITIVE LANDSCAPE

  • 13.1 INTRODUCTION
  • 13.2 KEY MARKET DEVELOPMENTS
  • 13.3 KEY PLAYERS' STRATEGIES
  • 13.4 REVENUE ANALYSIS OF KEY MARKET PLAYERS
    • FIGURE 39 REVENUE SHARE ANALYSIS OF KEY PLAYERS OPERATING IN DENTAL BONE GRAFT SUBSTITUTES MARKET
  • 13.5 MARKET SHARE ANALYSIS
    • FIGURE 40 MARKET SHARE ANALYSIS, BY KEY PLAYER, 2023
    • TABLE 183 DENTAL BONE GRAFT SUBSTITUTES MARKET: DEGREE OF COMPETITION
  • 13.6 COMPETITIVE SITUATION AND TRENDS
    • 13.6.1 PRODUCT LAUNCHES & APPROVALS
    • TABLE 184 DENTAL BONE GRAFT SUBSTITUTES MARKET: PRODUCT LAUNCHES & APPROVALS, MAY 2020-DECEMBER 2021
    • 13.6.2 DEALS
    • TABLE 185 DENTAL BONE GRAFT SUBSTITUTES MARKET: DEALS, DECEMBER 2022-JANUARY 2024
    • 13.6.3 EXPANSIONS
    • TABLE 186 DENTAL BONE GRAFT SUBSTITUTES MARKET: EXPANSIONS, APRIL 2021
  • 13.7 COMPANY EVALUATION MATRIX: KEY PLAYERS
    • 13.7.1 STARS
    • 13.7.2 EMERGING LEADERS
    • 13.7.3 PERVASIVE PLAYERS
    • 13.7.4 EMERGING PLAYERS
    • FIGURE 41 DENTAL BONE GRAFT SUBSTITUTES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
    • 13.7.5 FOOTPRINT ANALYSIS
    • FIGURE 42 OVERALL COMPANY FOOTPRINT
    • TABLE 187 COMPANY PRODUCT FOOTPRINT
    • TABLE 188 COMPANY APPLICATION FOOTPRINT
    • TABLE 189 COMPANY MECHANISM FOOTPRINT
    • TABLE 190 COMPANY END USER FOOTPRINT
    • TABLE 191 COMPANY REGIONAL FOOTPRINT
  • 13.8 COMPANY EVALUATION MATRIX: START-UPS/SMES
    • 13.8.1 PROGRESSIVE COMPANIES
    • 13.8.2 STARTING BLOCKS
    • 13.8.3 RESPONSIVE COMPANIES
    • 13.8.4 DYNAMIC COMPANIES
    • FIGURE 43 DENTAL BONE GRAFT SUBSTITUTES MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2023
    • 13.8.5 COMPETITIVE BENCHMARKING
    • TABLE 192 DENTAL BONE GRAFT SUBSTITUTES MARKET: DETAILED LIST OF KEY START-UPS/SMES
  • 13.9 BRAND/PRODUCT COMPARATIVE ANALYSIS
  • 13.10 R&D EXPENDITURE OF KEY PLAYERS
  • 13.11 INVESTMENT LANDSCAPE
    • FIGURE 44 DENTAL BONE GRAFT SUBSTITUTES MARKET: FUNDING ANALYSIS, 2019-2023
    • FIGURE 45 MOST VALUED FIRMS IN DENTAL BONE GRAFT SUBSTITUTES MARKET, 2023 (USD BILLION)
  • 13.12 VALUATION AND FINANCIAL MATRICES OF DENTAL BONE GRAFT SUBSTITUTES MARKET

14 COMPANY PROFILES

  • 14.1 KEY PLAYERS

(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**

    • 14.1.1 DENTSPLY SIRONA INC.
    • TABLE 193 DENTSPLY SIRONA INC.: BUSINESS OVERVIEW
    • FIGURE 46 DENTSPLY SIRONA INC.: COMPANY SNAPSHOT
    • TABLE 194 DENTSPLY SIRONA INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 195 DENTSPLY SIRONA INC.: DEALS
    • 14.1.2 ENVISTA HOLDINGS CORPORATION
    • TABLE 196 ENVISTA HOLDINGS CORPORATION: BUSINESS OVERVIEW
    • FIGURE 47 ENVISTA HOLDINGS CORPORATION: COMPANY SNAPSHOT
    • TABLE 197 ENVISTA HOLDINGS CORPORATION: PRODUCTS/SERVICES/ SOLUTIONS OFFERED
    • TABLE 198 ENVISTA HOLDINGS CORPORATION: PRODUCT LAUNCHES & APPROVALS
    • TABLE 199 ENVISTA HOLDINGS CORPORATION: DEALS
    • 14.1.3 JOHNSON & JOHNSON
    • TABLE 200 JOHNSON & JOHNSON: BUSINESS OVERVIEW
    • FIGURE 48 JOHNSON & JOHNSON: COMPANY SNAPSHOT
    • TABLE 201 JOHNSON & JOHNSON: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 202 JOHNSON & JOHNSON: DEALS
    • 14.1.4 INSTITUT STRAUMANN AG
    • TABLE 203 INSTITUT STRAUMANN AG: BUSINESS OVERVIEW
    • FIGURE 49 INSTITUT STRAUMANN AG: COMPANY SNAPSHOT
    • TABLE 204 INSTITUT STRAUMANN AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 205 INSTITUT STRAUMANN AG: PRODUCT LAUNCHES & APPROVALS
    • TABLE 206 INSTITUT STRAUMANN AG : DEALS
    • TABLE 207 INSTITUT STRAUMANN AG: OTHER DEVELOPMENTS
    • 14.1.5 MEDTRONIC, PLC
    • TABLE 208 MEDTRONIC, PLC: BUSINESS OVERVIEW
    • FIGURE 50 MEDTRONIC, PLC: COMPANY SNAPSHOT
    • TABLE 209 MEDTRONIC, PLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 210 MEDTRONIC PLC: DEALS
    • TABLE 211 MEDTRONIC PLC: EXPANSIONS
    • 14.1.6 ZIMVIE INC.
    • TABLE 212 ZIMVIE INC.: BUSINESS OVERVIEW
    • FIGURE 51 ZIMVIE INC.: COMPANY SNAPSHOT
    • TABLE 213 ZIMVIE INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 214 ZIMVIE INC: DEALS
    • 14.1.7 HENRY SCHEIN, INC.
    • TABLE 215 HENRY SCHEIN, INC.: BUSINESS OVERVIEW
    • FIGURE 52 HENRY SCHEIN, INC.: COMPANY SNAPSHOT
    • TABLE 216 HENRY SCHEIN, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 217 HENRY SCHEIN, INC.: PRODUCT LAUNCHES & APPROVALS
    • TABLE 218 HENRY SCHEIN, INC.: DEALS
    • 14.1.8 RTI SURGICAL
    • TABLE 219 RTI SURGICAL: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 220 RTI SURGICAL: DEALS
    • 14.1.9 LIFENET HEALTH
    • TABLE 221 LIFENET HEALTH: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • 14.1.10 DENTIUM CO., LTD.
    • TABLE 222 DENTIUM CO., LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • 14.1.11 GEISTLICH PHARMA AG
    • TABLE 223 GEISTLICH PHARMA AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • 14.1.12 STRYKER CORPORATION
    • TABLE 224 STRYKER CORPORATION: BUSINESS OVERVIEW
    • FIGURE 53 STRYKER CORPORATION: COMPANY SNAPSHOT
    • TABLE 225 STRYKER CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 226 STRYKER CORPORATION: DEALS
    • 14.1.13 INTEGRA LIFESCIENCES HOLDINGS CORPORATION
    • TABLE 227 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: BUSINESS OVERVIEW
    • FIGURE 54 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT
    • TABLE 228 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 229 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: PRODUCT LAUNCHES & APPROVALS
    • TABLE 230 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: DEALS
    • 14.1.14 TISSUE REGENIX GROUP PLC
    • TABLE 231 TISSUE REGENIX GROUP PLC: BUSINESS OVERVIEW
    • FIGURE 55 TISSUE REGENIX GROUP PLC: COMPANY SNAPSHOT
    • TABLE 232 TISSUE REGENIX GROUP PLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 233 TISSUE REGENIX GROUP PLC: PRODUCT LAUNCHES & APPROVALS
    • TABLE 234 TISSUE REGENIX GROUP PLC: DEALS
    • TABLE 235 TISSUE REGENIX GROUP PLC: OTHER DEVELOPMENTS
    • 14.1.15 KURARAY CO., LTD.
    • TABLE 236 KURARAY CO., LTD.: BUSINESS OVERVIEW
    • FIGURE 56 KURARAY CO., LTD.: COMPANY SNAPSHOT
    • TABLE 237 KURARAY CO., LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 238 KURARAY CO., LTD.: DEALS
    • TABLE 239 KURARAY CO., LTD.: OTHER DEVELOPMENTS
    • 14.1.16 BEGO GMBH & CO. KG
    • TABLE 240 BEGO GMBH & CO. KG: BUSINESS OVERVIEW
    • TABLE 241 BEGO GMBH & CO. KG: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 242 BEGO GMBH & CO. KG: DEALS
    • 14.1.17 YOUNG INNOVATIONS
    • TABLE 243 YOUNG INNOVATIONS: BUSINESS OVERVIEW
    • TABLE 244 YOUNG INNOVATIONS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 245 YOUNG INNOVATIONS: DEALS
    • 14.1.18 KEYSTONE DENTAL
    • TABLE 246 KEYSTONE DENTAL: BUSINESS OVERVIEW
    • TABLE 247 KEYSTONE DENTAL: PRODUCTS/SERVICES/SOLUTIONS OFFERED
    • TABLE 248 KEYSTONE DENTAL: DEALS
  • 14.2 OTHER PLAYERS
    • 14.2.1 NOVABONE
    • 14.2.2 BOTISS BIOMATERIALS GMBH
    • 14.2.3 REGENITY
    • 14.2.4 OSTEOGENICS BIOMEDICAL
    • 14.2.5 HANNOX INTERNATIONAL CORP.
    • 14.2.6 MEYER-HAAKE GMBH
    • 14.2.7 AROA BIOSURGERY LTD.
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

15 APPENDIX

  • 15.1 DISCUSSION GUIDE
  • 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 15.3 CUSTOMIZATION OPTIONS
  • 15.4 RELATED REPORTS
  • 15.5 AUTHOR DETAILS